VIDASYM, INC

Address

1673 CEDAR GLEN DR
LIBERTYVILLE, IL, 60048-3924

Information

DUNS: 830016551
# of Employees: 0

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Novel drug VS-105 for treatment of osteoporosis

    Amount: $1,480,983.00

    DESCRIPTION provided by applicant Osteoporosis is a major public health threat The American Association of Orthopaedic Surgeons estimates that the cost of treating patients with a low energy frac ...

    SBIRPhase II2016Department of Health and Human Services
  2. New drug VS-110 for treating inflammatory bowel diseases

    Amount: $299,216.00

    DESCRIPTION (provided by applicant): Inflammatory bowel diseases (IBD) involve chronic inflammation of all or part of the digestive tract. Symptoms may include abdominal pain, severe diarrhea and maln ...

    STTRPhase I2013Department of Health and Human Services
  3. Clinical Development of a Stable Glucagon Formulation for Bi-hormonal Pump

    Amount: $278,579.00

    DESCRIPTION (provided by applicant): Osteoporosis is a major public health threat. National Osteoporosis Foundation estimated that the US national direct expenditures for osteoporotic hip fractures w ...

    SBIRPhase I2013Department of Health and Human Services
  4. Novel drug VS-105 for treatment of diabetic nephropathy

    Amount: $159,647.00

    DESCRIPTION (provided by applicant): Twenty-six million people in America have chronic kidney disease (CKD). Diabetes is by far the leading cause of CKD (diabetic nephropathy), accounting for 44% of n ...

    STTRPhase I2012Department of Health and Human Services
  5. New drug VS-501 for treating hyperphosphatemia in chronic kidney disease

    Amount: $217,354.00

    DESCRIPTION (provided by applicant): Twenty-six million people in America have chronic kidney disease (CKD). Despite the various treatments available to CKD patients, the five-year survival rate is ~3 ...

    SBIRPhase I2012Department of Health and Human Services
  6. New drug Vida-5 for treating chronic kidney disease progression

    Amount: $219,123.00

    DESCRIPTION (provided by applicant): Twenty-six million people in America have chronic kidney disease (CKD). Anemia, cardiovascular diseases, secondary hyperparathyroidism, renal osteodystrophy and ot ...

    SBIRPhase I2011Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government